細胞分離市場- 世界の産業規模、シェア、動向、機会、および予測、2018年～2028年製品別、細胞タイプ別、供給源別、技術別、用途別、エンドユーザー別、地域別、競合別に区分

世界の細胞分離市場は2022年に40億3,000万米ドルの規模に達し、2028年までの年間平均成長率（CAGR）は13.04%と予想され、目覚ましい成長を遂げようとしています。

細胞選別としても知られる細胞分離は、異種混合細胞集団から特定の細胞を同定し分離するプロセスです。これらの標的細胞はその細胞タイプに基づいて分離されます。細胞分離の一般的な方法には、磁気活性化細胞分離、濾過、遠心分離、フローサイトメトリーなどがあります。

細胞分離はリボ核酸（RNA）の発現を分析することにより、病気の診断、細胞研究、治療開発において極めて重要な役割を果たします。細胞の実験的分析を簡素化し、サンプル内の他の細胞タイプからの干渉を減少させます。その結果、がん研究、幹細胞生物学、免疫学、神経学などの分野で幅広く応用されています。単離細胞を利用した革新的な技術の例として、細胞膜を横切る荷電粒子の動きを調べるパッチクランプ電気生理学があります。単離細胞は細胞培養にも役立っており、単一細胞が増殖して細胞のコロニーを形成します。

さらに、細胞の分離は様々な治療にも応用されています。例えば、1型糖尿病患者を治療するために膵島細胞を分離、培養、移植することができます。

市場促進要因

慢性疾患の増加

糖尿病やがんなどの慢性疾患の罹患率の増加により、細胞ベースの治療に対する需要が増加しています。さらに、細胞分離は様々な診断実験や慢性疾患の調査において重要な役割を果たしています。創薬においては、細胞挙動、疾患反応、薬物影響の研究に細胞分離が不可欠です。がん、自己免疫疾患、遺伝的疾患など幅広い疾患の治療のための組換えタンパク質治療薬を開発するための創薬技術において、細胞分離ツールはますます活用されるようになっています。慢性疾患の世界の流行は、研究、医薬品開発、臨床試験における分離ヒト細胞の応用をさらに増幅させています。従って、慢性疾患の罹患率の増加に牽引された細胞ベースの治療に対する需要の高まりは、細胞分離ツールに対するニーズの増大をもたらしました。

製薬・バイオテクノロジー業界における調査活動の急増

細胞分離/細胞単離市場の堅調な成長は、製薬・バイオテクノロジー産業における調査活動の大幅な増加に起因しています。この急増は、疾病数の急激な増加、発達したインフラ、技術の進歩に対応するものです。これらの要因が、効果的な細胞分離・分離技術の必要性を助長し、市場成長をさらに後押ししています。

さらに、ラボの自動化に対する需要の高まりも、細胞分離/細胞単離市場の成長を高める上で極めて重要な役割を果たしています。研究室がプロセスの合理化と効率化を追求するにつれ、細胞分離・分離のための自動化ソリューションの採用がますます重要になってきています。その結果、より多くの企業や研究機関が科学的活動における研究室自動化の利点やメリットを認識するようになり、市場の拡大を後押ししています。後進国を含む数多くのバイオテクノロジー企業がこの市場に参入しています。製薬会社は、新薬を開発し技術革新を促進するために細胞分離技術を利用する可能性が高いです。これらの企業は、拡大する幹細胞調査分野をサポートするため、重要な独立部門を買収しています。バイオテクノロジーと製薬企業のセクターは、細胞分離技術によって促進されるCAR-Tのような薬や治療の進歩によって推進されると予想されます。現在、米国には449社の公開バイオテクノロジー会社が存在し、バイオテクノロジー・製薬会社の市場を牽引すると予想されています。

生物医学研究活動を強化する政府の政策

近年、生物医学研究活動を支援・促進するために世界各国の政府によって実施される取り組みや政策が著しく急増しています。これは主に、高齢化人口の増加や慢性疾患の有病率の上昇に加え、このような研究の重要性に対する顧客の意識の高まりが背景にあります。その結果、細胞分離市場は急速な成長を遂げています。

バイオテクノロジー分野への大規模な投資とヘルスケア・インフラの継続的な改善により、細胞分離市場の拡大がさらに促進されると予想されます。こうした投資や進歩は市場全体の成長に寄与するだけでなく、細胞分離・分離分野における技術革新や技術進歩も促進します。

高齢者人口の増加に伴い臨床試験と調査の需要が増加

65歳以上で構成される高齢者人口は、若年層と比較してがんや神経疾患などの慢性疾患にかかりやすいです。特筆すべきは、老年人口が急速に増加していることで、こうした健康上の懸念に対処する意義がさらに大きくなっていることです。65歳以上の高齢者の増加に伴い、アルツハイマー病、認知症、がん、免疫疾患などの有病率は著しく上昇すると予想されます。

その結果、これらの症状に対応するための矯正治療に対する需要が急増します。この需要の急増は、臨床試験を含む様々な研究活動において重要な役割を果たす細胞分離製品の分野にも拡大すると予測されます。その結果、細胞分離技術の世界市場は、これらの要因によって大幅な成長が見込まれます。

主な市場課題

技術熟練者の不足

この分野における技術的に有能な労働者の不足は、細胞分離手順に関する厳しい規則やコンプライアンスの存在に対する懸念の高まりと相まって、市場全体の拡大を抑制すると予測されます。さらに、細胞分離技術のインプラント治療に関連する高コストは、今後数年間の市場成長に大きな脅威となる可能性があります。こうしたことから、これらの課題を克服し、持続的な市場成長を促進するための戦略的対策と革新的ソリューションの必要性が浮き彫りになっています。

研究室ベースの診断から在宅検査へのシフト

顧客の意識の高まりにより、ラボベースの診断からホームベースの検査へのシフトが進み、合併症の可能性が減少し、技術が大幅に進歩しました。その結果、細胞単離／細胞分離市場の成長は縮小すると予想されます。さらに、サービス契約や原材料に関連する高コストが市場成長の妨げになる可能性もあります。これらの要因は総体的に細胞分離市場が直面する課題の一因となっており、これらの懸念に対処し、業界の持続的成長を確保するための戦略的ソリューションの必要性が強調されています。

主要市場動向

技術の進歩

細胞分離技術市場は、今後数年間で大きな成長機会に恵まれることが予想されます。この背景には、純度収率の向上や細胞分離時間の短縮など、細胞ベースの技術における急速な技術進歩があります。さらに、細胞ベースの技術を改善するための政府のイニシアチブの高まりや、細胞分離技術の費用対効果の高さも、市場成長に寄与すると予想されます。さらに、新興諸国ではヘルスケアのインフラが発達しているため、細胞分離技術の採用や導入に有利な環境が整っています。これらすべての要因が相まって、細胞分離技術市場は当面大幅な拡大が見込まれます。

製品の革新

世界の細胞分離市場の成長は製品提供の進歩によって促進されています。この市場における製品イノベーションは、主に様々な慢性疾患や感染症に対する細胞ベースの研究における自動化ツールの需要の増加によってもたらされています。BDやQIAGENなどの市場の主要企業は、継続的な製品改良に専念しています。例えば、2019年3月、BDは、BD FACSDuet自動フローサイトメトリーシステムを発表しました。これは、BD FACSLyric臨床フローサイトメーターでアッセイを実行する際に、エラーを最小限に抑え、ユーザーによる手動操作の必要性を減らすことにより、臨床検査室の効率を高める完全自動サンプル調製装置です。バイオ・ラッドのような他のベンダーは、フローサイトメトリー用試薬の開発に注力しています。2020年11月、Bio-Rad Laboratories, Inc.はStarBright Blue 700、StarBright Violet 440、StarBright Violet 610色素を発売し、フローサイトメトリー用の最大輝度と分解能の向上を実現しました。従って、既存の市場プレーヤーによる継続的な製品の進歩が市場の成長を促進し、これらの製品の売上増加に寄与しています。

セグメント別インサイト

細胞タイプ別インサイト

細胞タイプに基づき、市場はヒト細胞と動物細胞に区分されます。2022年には、ヒト細胞カテゴリーが収益シェアでトップに浮上しました。これは、がんやヒトの研究が重視されるようになったこと、バイオ医薬品の開発、臨床試験、研究において分離ヒト細胞の応用範囲が広くなったことに起因しています。さらに、先進国における個別化医療に対する魅力的な支払い政策が、ヒト細胞単離の需要をさらに高めています。予測期間中、動物細胞セグメントも有益な成長を遂げると予測されています。新薬の開発は政府機関、商業セクター、ヘルスケア組織から大きな注目を集めており、それがこのセグメントの成長を促進しています。動物細胞は、毒性、薬物動態、有効性の評価を可能にし、新薬の発見と開発において重要な役割を果たしています。

手法別洞察

技術セグメントに基づいて、市場は遠心分離ベースの細胞分離、表面マーカーベースの細胞分離、ろ過ベースの細胞分離に区分されます。遠心分離ベースの細胞分離セグメントは、2022年に最大の収益シェアを占め、細胞分離市場の支配的な力となっています。この技術は学術機関、研究センター、バイオテクノロジー/バイオ製薬会社で広く利用されています。遠心分離は細胞分離において重要な役割を果たしており、差動遠心分離と密度勾配遠心分離の両方が一般的に採用されています。密度勾配遠心分離は粒子分離のために分子量を利用し、差動遠心分離は細胞膜を破壊するために溶解液を用います。

今後、表面マーキングとろ過の両分野で大きな成長が見込まれます。この市場拡大は、主に製品開拓と製造インフラへの企業投資の増加によってもたらされます。メーカーは、最終製品の品質を高めるため、革新的な表面マーカーやろ過システムを生産・調査方法に活用しています。

地域別洞察

北米市場は、慢性疾患の有病率の増加、個別化医療に対する需要の高まり、細胞ベースの研究開発に対する政府の資金援助などを背景に、今後数年間は世界の細胞分離業界をリードしていくものと思われます。先進的なヘルスケアシステム、強固な研究開発部門、バイオテクノロジー研究への投資の増加により、北米は最も大きな収益成長が見込まれます。

アジア太平洋は、ヘルスケアコストの高騰、患者数の多さ、最先端の細胞分離法への関心の高まりといった要因から、細胞分離市場の急速な拡大が予想されます。同地域には、慢性疾患の発生率が上昇傾向にある中国やインドなどの新興国があります。さらに、熟練した人材が入手しやすく、製造コストも手ごろであることから、この地域には細胞分離業界の大手企業が多数進出してくると予想されます。

欧州市場は、ライフサイエンス研究開発への政府支出の増加や慢性疾患の蔓延といった要因によって、緩やかな成長を示すと予測されます。サーモフィッシャーサイエンティフィック、STEMCELLテクノロジーズ、メルクKGaAなど、細胞分離市場の主要企業はこの地域に拠点を置く注目すべき企業です。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 細胞分離の世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別（消耗品、器具）
  • 細胞タイプ別（ヒト細胞、動物細胞）
  • ソース別（骨髄、臍帯血/胚性幹細胞、脂肪組織）
  • 手法別（遠心分離法、表面マーカー法、ろ過法）
  • 用途別（生体分子単離、がん研究、幹細胞研究、体外診断、その他）
  • エンドユーザー別（バイオテクノロジーおよびバイオ製薬会社、研究所および調査機関、病院および診断研究所、細胞バンク）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米の細胞分離市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 細胞タイプ別
  • ソース別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の細胞分離市場の展望

• 市場規模と予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 細胞タイプ別
  • ソース別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の細胞分離市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 細胞タイプ別
  • ソース別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米細胞分離市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 細胞タイプ別
  • ソース別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの細胞分離市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 細胞タイプ別
  • ソース別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 細胞分離の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Service Offerings
• Recent Developments
• Key Personnel
• SWOT Analysis
  • Becton, Dickinson & Company
  • Merck KGaA（Millipore Sigma）
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation（Cytiva）
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Cell Isolation Market reached a value of USD 4.03 Billion in 2022 and is poised for remarkable growth, with an expected Compound Annual Growth Rate (CAGR) of 13.04% through 2028. Cell isolation, also known as cell sorting, is the process of identifying and separating specific cells from a heterogeneous mixture of cell populations. These targeted cells are isolated and separated based on their cell type. Common methods for cell isolation include magnet-activated cell isolation, filtration, centrifugation, and flow cytometry.

Cell isolation plays a pivotal role in diagnosing diseases, conducting cellular research, and developing therapies by analyzing ribonucleic acid (RNA) expressions. It simplifies the experimental analysis of cells and reduces interference from other cell types within the sample. Consequently, it finds extensive applications in fields such as cancer research, stem cell biology, immunology, and neurology. An example of an innovative technique that utilizes isolated cells is patch-clamp electrophysiology, which examines the movement of charged particles across the cell membrane. Isolated cells are also instrumental in cell culture, where a single cell multiplies to form a colony of cells.

Moreover, cell isolation has various therapeutic applications. For instance, pancreatic islet cells can be isolated, cultured, and transplanted to treat patients with Type 1 Diabetes.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The growing incidence of chronic diseases, such as diabetes and cancer, has led to an increased demand for cell-based therapies. Additionally, cell isolation plays a crucial role in various diagnostic experiments and research on chronic diseases. In drug discovery, cell isolation is essential for studying cellular behavior, disease response, and drug impact. Cell isolation tools are increasingly utilized in drug discovery techniques to develop recombinant protein therapeutics for treating a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. The global prevalence of chronic diseases has further amplified the applications of isolated human cells in research, drug development, and clinical trials. Therefore, the rising demand for cell-based therapies, driven by the growing incidence of chronic diseases, has resulted in an increased need for cell isolation tools.

The growth of chronic diseases, such as diabetes, obesity, arthritis, heart disorders, and cancer, is influenced by factors like increased sedentary lifestyle, global population aging, and higher rates of cigarette smoking and alcohol consumption. According to Imperial College London, chronic illnesses were projected to account for over 70% of global fatalities in 2020, with more than 41 million deaths annually. Approximately 17 million of these deaths are considered premature, occurring at a younger age than expected.

Consequently, the demand for cellular therapies to address chronic diseases is escalating alongside the burden of these conditions. This has led to increased focus and funding in research to develop effective remedies. As a result, the global market for cell isolation technologies is being driven by the growing activities in cellular research.

Rapid Increase in The Research Activities In The Pharmaceutical And Biotechnological Industries

The robust growth of the Cell Isolation/Cell isolation Market can be attributed to the significant increase in research activities within the pharmaceutical and biotechnological industries. This surge is in response to the rapid rise in the number of diseases, as well as the presence of well-developed infrastructures and advancements in technology. These factors contribute to the need for effective cell isolation and separation techniques, which further drives the market growth.

Moreover, the growing demand for laboratory automation has also played a pivotal role in enhancing the growth of the Cell Isolation/Cell isolation Market. As laboratories seek to streamline their processes and improve efficiency, the adoption of automated solutions for cell isolation and separation becomes increasingly important. This, in turn, fuels the expansion of the market, as more companies and research institutions recognize the benefits and advantages of laboratory automation in their scientific endeavors. Numerous biotechnology companies, including those from underdeveloped nations, are venturing into the market. Pharmaceutical corporations are likely to utilize cell isolation techniques to develop new medications and foster innovation. These companies have acquired significant independent units to support the expanding stem cell research field. The biotechnology and pharmaceutical firms' sector is expected to be propelled by the advancements in medications and treatments, such as CAR-T, facilitated by cell isolation technologies. Currently, there are 449 public biotech companies operating in the U.S., which is anticipated to drive the market for biotechnology and pharmaceutical companies.

Government's Policies to Enhance Biomedical Research Activities

In recent years, there has been a remarkable surge in initiatives and policies implemented by governments worldwide to support and promote biomedical research activities. This is primarily driven by the increasing awareness among customers about the significance of such research, as well as the growing number of aging population and the rising prevalence of chronic diseases. Consequently, the Cell Isolation Market has experienced a rapid growth trajectory.

Substantial investments in the biotechnology sector and continuous improvements in the healthcare infrastructure are expected to further stimulate the expansion of the Cell Isolation Market. These investments and advancements not only contribute to the overall growth of the market but also foster innovation and technological advancements in the field of cell isolation and separation.

Demand For Clinical Trials and Research Is Increasing As The Geriatric Population Grows

The senior population, comprising individuals aged 65 and over, is more prone to chronic illnesses such as cancer and neurological disorders when compared to the younger population. Notably, the geriatric population is experiencing rapid growth, which further magnifies the significance of addressing these health concerns. With the increasing number of individuals aged 65 and over, the prevalence of conditions like Alzheimer's, dementia, cancer, and immunological illnesses is expected to rise significantly.

Consequently, there will be an escalating demand for corrective treatments to cater to these conditions. This surge in demand is also projected to extend to the field of cell isolation products, which play a crucial role in various research endeavors, including clinical trials. As a result, the global market for cell isolation technologies is anticipated to witness substantial growth, driven by these factors.

Key Market Challenges

Lack of Technically Skilled Individuals

The shortage of technically competent workers in the field, coupled with the increasing concerns about the existence of tight rules and compliances for cell separation procedures, are projected to restrain the overall market expansion. Moreover, the high cost associated with cell separation technology implant treatments can potentially pose a significant threat to the growth of the market in the coming years. These factors highlight the need for strategic measures and innovative solutions to overcome these challenges and foster sustainable market growth.

Shift From Lab-Based Diagnosis to Home-Based Testing

The shift from lab-based diagnosis to home-based testing, driven by increased customer awareness, has led to a decrease in the chances of complications and significant advancements in technology. As a result, the growth of the Cell Isolation/Cell Separation Market is anticipated to be reduced. Additionally, the market growth may be hampered by the high costs associated with service contracts and raw materials. These factors collectively contribute to the challenges faced by the Cell Isolation Market, emphasizing the need for strategic solutions to address these concerns and ensure sustained growth in the industry.

Key Market Trends

Technological Advancement

It is anticipated that the cell separation technology market will experience significant growth opportunities in the coming years. This can be attributed to the rapid technological advancements in cell-based technology, such as higher purity yield and reduced cell isolation time. Additionally, the rise in government initiatives to improve cell-based technology and the cost-effectiveness of cell separation techniques are expected to contribute to market growth. Furthermore, the well-developed healthcare infrastructure in developing countries provides a favorable environment for the adoption and implementation of cell separation technologies. All these factors combined make the cell separation technology market poised for substantial expansion in the foreseeable future.

Product Innovations

The growth of the global cell isolation market is being fueled by advancements in the product offerings. Product innovations in this market are primarily driven by the increasing demand for automated tools in cell-based research for various chronic and infectious diseases. Key players in the market, such as BD and QIAGEN, are dedicated to continuous product improvement. For instance, in March 2019, BD introduced the BD FACSDuet automated flow cytometry system, a fully automated sample preparation instrument that enhances the efficiency of clinical laboratories by minimizing errors and reducing the need for manual user interactions when running assays on the BD FACSLyric clinical flow cytometer. Other vendors, like Bio-Rad, are focused on the development of reagents for flow cytometry. In November 2020, Bio-Rad Laboratories, Inc. launched StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 dyes, which provide maximum brightness and improved resolution for flow cytometry. Hence, the continuous product advancements by established market players drive market growth and contribute to increased sales of these products.

Segmental Insights

Cell Type Insights

Based on the cell type, the market is segmented into human cells and animal cells. In 2022, the human cell category emerged as the leader in terms of revenue share. This can be attributed to the growing emphasis on cancer and human research, as well as the wide range of applications of isolated human cells in biopharmaceutical development, clinical trials, and research. Moreover, the attractive payment policies for personalized medicine in industrialized countries further contribute to the demand for human cell isolation. It is projected that the animal cells segment will also witness profitable growth during the forecast period. The development of novel drugs has garnered significant attention from government bodies, the commercial sector, and healthcare organizations, thereby driving the growth of this segment. Animal cells play a crucial role in the discovery and development of new drugs, enabling the assessment of toxicity, pharmacokinetics, and effectiveness.

Technique Insights

Based on the technique segment, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment, accounted for the largest revenue share in 2022, has been a dominant force in the cell separation market. This technique is widely utilized by academic institutions, research centers, and biotechnology/biopharmaceutical companies. Centrifugation plays a crucial role in cell isolation, with both differential centrifugation and density gradient centrifugation commonly employed. Density gradient centrifugation leverages molecular weights for particle separation, while differential centrifugation employs lysates to disrupt cell membranes.

Looking ahead, significant growth is expected in both the surface marking and filtration segments. This market expansion is primarily driven by product development and increased corporate investments in manufacturing infrastructure. Manufacturers utilize innovative surface markers and filtration systems in their production and research processes to enhance the quality of the final product.

Regional Insights

The North American market is poised to lead the global cell isolation industry in the coming years, driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and government funding for cell-based research and development. With its advanced healthcare system, robust research and development sector, and increasing investment in biotechnology research, North America is expected to witness the most significant revenue growth.

Asia Pacific is anticipated to experience rapid expansion in the cell isolation market due to factors such as escalating healthcare costs, a large patient base, and growing interest in cutting-edge cell separation methods. The region boasts several emerging nations, including China and India, where the incidence of chronic diseases is on the rise. Additionally, the accessibility to skilled personnel and affordable production costs is expected to attract numerous major players in the cell isolation industry to the region.

The European market is projected to exhibit moderate growth, driven by factors such as increased government spending on life sciences research and development and the prevalence of chronic disorders. Key players in the cell isolation market, such as Thermo Fisher Scientific, STEMCELL Technologies, and Merck KGaA, are among the notable companies based in the region.

Key Market Players

• Becton, Dickinson & Company

• Merck KGaA (Millipore Sigma)

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories Inc.

• Terumo Corporation

• PluriSelect Life Science UG & Co. KG

• Danaher Corporation (Cytiva)

• STEMCELL Technologies Inc.

• Corning Inc.

• Akadeum Life Sciences Inc.

Report Scope:

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Product:

• Consumables
• Instruments

Cell Isolation Market, By Cell Type:

• Human Cells
• Animal Cells

Cell Isolation Market, By Source:

• Bone Marrow
• Cord Blood/Embryonic Stem Cells
• Adipose Tissue

Cell Isolation Market, By Technique:

• Centrifugation-Based Cell Isolation
• Surface Marker-Based Cell Isolation
• Filtration-Based Cell

Cell Isolation Market, By Application:

• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• In Vitro Diagnostic
• Others

Cell Isolation Market, By End User:

• Biotechnology and Biopharmaceutical Companies
• Research Laboratories and Institutes
• Hospitals and Diagnostic Laboratories
• Cell Banks

Cell Isolation Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations:

• Global Cell Isolation market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Isolation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables and Instruments)
  • 5.2.2. By Cell Type (Human Cells and Animal Cells)
  • 5.2.3. By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue)
  • 5.2.4. By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation)
  • 5.2.5. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
  • 5.2.6. By End User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks)
  • 5.2.7. By Region
  • 5.2.8. By Company (2022)
• 5.3. Market Map

6. North America Cell Isolation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Cell Type
  • 6.2.3. By Source
  • 6.2.4. By Technique
  • 6.2.5. By Application
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Isolation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Cell Type
      • 6.3.1.2.3. By Source
      • 6.3.1.2.4. By Technique
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Cell Isolation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Cell Type
      • 6.3.2.2.3. By Source
      • 6.3.2.2.4. By Technique
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Cell Isolation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Cell Type
      • 6.3.3.2.3. By Source
      • 6.3.3.2.4. By Technique
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By End User

7. Europe Cell Isolation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Cell Type
  • 7.2.3. By Source
  • 7.2.4. By Technique
  • 7.2.5. By Application
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Isolation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Cell Type
      • 7.3.1.2.3. By Source
      • 7.3.1.2.4. By Technique
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By End User
      • 7.3.1.2.7.
  • 7.3.2. United Kingdom Cell Isolation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Cell Type
      • 7.3.2.2.3. By Source
      • 7.3.2.2.4. By Technique
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By End User
  • 7.3.3. Italy Cell Isolation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Cell Type
      • 7.3.3.2.3. By Source
      • 7.3.3.2.4. By Technique
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By End User
  • 7.3.4. France Cell Isolation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Cell Type
      • 7.3.4.2.3. By Source
      • 7.3.4.2.4. By Technique
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Cell Isolation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Cell Type
      • 7.3.5.2.3. By Source
      • 7.3.5.2.4. By Technique
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By End User

8. Asia-Pacific Cell Isolation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Cell Type
  • 8.2.3. By Source
  • 8.2.4. By Technique
  • 8.2.5. By Application
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Isolation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Cell Type
      • 8.3.1.2.3. By Source
      • 8.3.1.2.4. By Technique
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By End User
  • 8.3.2. India Cell Isolation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Cell Type
      • 8.3.2.2.3. By Source
      • 8.3.2.2.4. By Technique
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Cell Isolation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Cell Type
      • 8.3.3.2.3. By Source
      • 8.3.3.2.4. By Technique
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Cell Isolation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Cell Type
      • 8.3.4.2.3. By Source
      • 8.3.4.2.4. By Technique
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Cell Isolation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Cell Type
      • 8.3.5.2.3. By Source
      • 8.3.5.2.4. By Technique
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By End User

9. South America Cell Isolation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Cell Type
  • 9.2.3. By Source
  • 9.2.4. By Technique
  • 9.2.5. By Application
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Isolation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Cell Type
      • 9.3.1.2.3. By Source
      • 9.3.1.2.4. By Technique
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By End User
  • 9.3.2. Argentina Cell Isolation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Cell Type
      • 9.3.2.2.3. By Source
      • 9.3.2.2.4. By Technique
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By End User
  • 9.3.3. Colombia Cell Isolation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Cell Type
      • 9.3.3.2.3. By Source
      • 9.3.3.2.4. By Technique
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By End User

10. Middle East and Africa Cell Isolation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Cell Type
  • 10.2.3. By Source
  • 10.2.4. By Technique
  • 10.2.5. By Application
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Isolation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Cell Type
      • 10.3.1.2.3. By Source
      • 10.3.1.2.4. By Technique
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By End User
  • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Cell Type
      • 10.3.2.2.3. By Source
      • 10.3.2.2.4. By Technique
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By End User
  • 10.3.3. UAE Cell Isolation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Cell Type
      • 10.3.3.2.3. By Source
      • 10.3.3.2.4. By Technique
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Cell Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Becton, Dickinson & Company
  • 15.5.2. Merck KGaA (Millipore Sigma)
  • 15.5.3. Thermo Fisher Scientific Inc.
  • 15.5.4. Bio-Rad Laboratories Inc.
  • 15.5.5. Terumo Corporation
  • 15.5.6. PluriSelect Life Science UG & Co. KG
  • 15.5.7. Danaher Corporation (Cytiva)
  • 15.5.8. STEMCELL Technologies Inc.
  • 15.5.9. Corning Inc.
  • 15.5.10. Akadeum Life Sciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer